It is technically against federal law to import drugs into the United States except those authorized by the manufacturer. This is how U.S. drugmakers can charge much higher prices domestically. The ban on drug reimportation allows drug manufacturers to price discriminate, charging different prices in different markets. This only works if you can prevent arbitrage, which is preventing someone bypassing the expensive products by importing cheaper ones.
Author: Devon Herrick
Traffic Fatalities Near Historic Lows, but Public Health Advocates Demand More Laws
Traffic fatalities have been inching up ever since covid. About 43,230 people died in 2021 the year after the Covid Pandemic. Traffic deaths are up 20% from a decade ago. Approximately 39,345 people died in 2024 compared 32,744 in 2014.
Obamacare is Obsolete and Incompatible with Personalized Medicine
Under Obamacare patient power has only gotten worse. In 2023 I paid nearly $8,000 for a health plan that required I spend a similar amount on medical care before it paid a nickel of my medical bills. The only health care dollars I controlled were the ones I took from my own pocket. Of course, that is how it is supposed to work in other markets. The difference is that government regulates risk. If I want a method to limit my risk of a costly, catastrophic health condition, I must buy Obamacare.
Should the FDA Make Drugmakers Prove their Drugs Work: Part II
How tough should the U.S. Food and Drug Administration (FDA) be when approving drugs? Currently drugmakers must not only show their drugs are safe (Phase 0 and Phase 1 trials), but also, they have the desired effect on the body for most people (Phase 2 and Phase 3).